Studying the molecular pathology of cytological samples from pancreatic and biliary ducts
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
Despite general development in cancer diagnostics pancreatic cancer remains one of the cancers with the poorest prognosis. The diagnosis is usually done in a late stage as reliable screening methods are not available. Resection increases the five year survival rate from 5% to 20% but only one in five pancreatic cancers is detected when the surgical resection is still possible. KRAS mutation is present in almost all cases and TP53, CDKN2A and SMAD4 mutations are common (40-60% of cases). A cytological brush sample can be obtained from pancreatic and biliary ducts. The sample is usually low in cellularity and microscopic diagnosis alone may be inconclusive. The inclusion of molecular pathology methods could clarify the diagnosis. The aim of this Master's Thesis was to study if pancreatic cancer associated mutations were detectable from the cytological samples and to evaluate the value and sensitivity of the molecular diagnostic methods used. 30 cytological samples from pancreatic and biliary ducts of pancreatic cancer patients were studied with droplet digital PCR (ddPCR) and next generation sequencing (NGS). KRAS mutation was detected in 63,3% with ddPCR and 57% with NGS. With NGS a mutation in TP53, CDKN2A and SMAD4 was found in 60%, 40% and 30% of the cases, respectively. In conclusion, the sensitivity of ddPCR was higher than NGS but neither were highly sensitive when studying KRAS mutation from samples with low tumor DNA yield. KRAS mutation was found to be unspecific for malignancy as it was found from 33% of 24 benign control samples studied with ddPCR. TP53, CDKN2A, and SMAD4 were detected with similar frequency than in literature when using NGS. Cytological samples hold potential for diagnostic use when suitable biomarkers and sensitive methods are used. ...
MetadataShow full item record
- Pro gradu -tutkielmat 
Showing items with similar title or keywords.
Primary sclerosing cholangitis dysplasia-carcinoma sequence : possibilities in early stage molecular pathology Mustamäki, Taru (2020)Primaarinen sklerosoiva kolangiitti, eli PSC on krooninen tulehduksellinen sappiteiden sairaus, joka aiheuttaa sappiteihin arpeutumista ja ahtaumia. PSC potilaista 20 % saa pelättynä huonoennusteisena komplikaationa ...
Somatic mutation profiles as molecular classifiers of ulcerative colitis‐associated colorectal cancer Mäki‐Nevala, Satu; Ukwattage, Sanjeevi; Olkinuora, Alisa; Almusa, Henrikki; Ahtiainen, Maarit; Ristimäki, Ari; Seppälä, Toni; Lepistö, Anna; Mecklin, Jukka‐Pekka; Peltomäki, Päivi (John Wiley & Sons, 2021)Ulcerative colitis increases colorectal cancer risk by mechanisms that remain incompletely understood. We approached this question by determining the genetic and epigenetic profiles of colitis‐associated colorectal carcinomas ...
Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer Tahkola, Kyösti; Ahtiainen, Maarit; Mecklin, Jukka-Pekka; Kellokumpu, Ilmo; Laukkarinen, Johanna; Tammi, Markku; Tammi, Raija; Väyrynen, Juha P.; Böhm, Jan (Nature Publishing Group, 2021)Hyaluronan (HA) accumulation has been associated with poor survival in various cancers, but the mechanisms for this phenomenon are still unclear. The aim of this study was to investigate the prognostic significance of ...
Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer Tahkola, Kyösti; Ahtiainen, Maarit; Kellokumpu, Ilmo; Mecklin, Jukka-Pekka; Laukkarinen Johanna; Laakkonen, Joni; Kenessey, Istvan; Jalkanen, Sirpa; Salmi, Marko; Böhm, Jan (Springer, 2021)Immune suppressing molecule CD73 is overexpressed in various cancers and associated with poor survival. Little is so far known about the predictive value of CD73 in pancreatic ductal adenocarcinoma (PDAC). The purpose of ...
Clinical characteristics of pancreatic and biliary tract cancers in Lynch syndrome : A retrospective analysis from the Finnish National Lynch Syndrome Research Registry Zalevskaja, Kristina; Mecklin, Jukka-Pekka; Seppälä, Toni T. (Frontiers Media SA, 2023)Introduction: Patients with Lynch syndrome (LS) have an increased lifetime risk of pancreatic cancer (PC) and biliary tract cancer (BTC). These cancers have a notoriously pessimistic prognosis due to late diagnosis and ...